Paper42819232PubMed
Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection.
Ouassaf M and 4 others. Front Chem, 2026.
Cite this record
ConductScience Library. Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection. Papers, record 42819232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42819232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of natural TLR4 modulators through network pharmacology and molecular modeling in SARS-CoV-2 Acinetobacter baumannii co-infection.
- Journal
- Front Chem
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-01
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33807410 | OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response. | Pathogens | 2021 | https://conductscience.org/library/papers/33807410 | PubMed |
| 2 | 29686833 | Natural Products with Toll-Like Receptor 4 Antagonist Activity. | Int J Inflam | 2018 | https://conductscience.org/library/papers/29686833 | PubMed |
| 3 | 35805952 | Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35805952 | PubMed |
| 4 | 19235177 | Scoring ligand similarity in structure-based virtual screening. | J Mol Recognit | 2009 | https://conductscience.org/library/papers/19235177 | PubMed |
| 5 | 34096718 | OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. | J Chem Theory Comput | 2021 | https://conductscience.org/library/papers/34096718 | PubMed |
| 6 | 40050633 | Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40050633 | PubMed |
| 7 | 39594506 | Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39594506 | PubMed |
| 8 | 36370105 | The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/36370105 | PubMed |
| 9 | 35484567 | Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease. | Chin Med | 2022 | https://conductscience.org/library/papers/35484567 | PubMed |
| 10 | 35746718 | Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. | Viruses | 2022 | https://conductscience.org/library/papers/35746718 | PubMed |
| 11 | 34451470 | Acinetobacter baumannii Infections in Times of COVID-19 Pandemic. | Pathogens | 2021 | https://conductscience.org/library/papers/34451470 | PubMed |
| 12 | 30518153 | Semisynthesis and Inhibitory Effects of Solidagenone Derivatives on TLR-Mediated Inflammatory Responses. | Molecules | 2018 | https://conductscience.org/library/papers/30518153 | PubMed |
| 13 | 30153074 | TLR-4/microRNA-125a/NF-κB signaling modulates the immune response to Mycobacterium tuberculosis infection. | Cell Cycle | 2018 | https://conductscience.org/library/papers/30153074 | PubMed |
| 14 | 18977229 | Taxanes inhibit human TLR4 signaling by binding to MD-2. | FEBS Lett | 2008 | https://conductscience.org/library/papers/18977229 | PubMed |
| 15 | 39081000 | Curcumin, a plant polyphenol with multiple physiological functions of improving antioxidation, anti-inflammation, immunomodulation and its application in poultry production. | J Anim Physiol Anim Nutr (Berl) | 2024 | https://conductscience.org/library/papers/39081000 | PubMed |
| 16 | 38430908 | The transcription factor NF-κB orchestrates nucleosome remodeling during the primary response to Toll-like receptor 4 signaling. | Immunity | 2024 | https://conductscience.org/library/papers/38430908 | PubMed |
| 17 | 33622601 | Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation. | Trends Immunol | 2021 | https://conductscience.org/library/papers/33622601 | PubMed |
| 18 | 39258172 | Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39258172 | PubMed |
| 19 | 37285618 | Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike. | Curr Opin Struct Biol | 2023 | https://conductscience.org/library/papers/37285618 | PubMed |
| 20 | 35844614 | Acinetobacter baumannii Outer Membrane Protein A Induces Pulmonary Epithelial Barrier Dysfunction and Bacterial Translocation Through The TLR2/IQGAP1 Axis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35844614 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42819232
GET https://conductscience.org/api/papers/v1/42819232/references?page=2